Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML.
Yilmaz M, Alfayez M, DiNardo CD, Borthakur G, Kadia TM, Konopleva MY, Loghavi S, Kanagal-Shamanna R, Patel KP, Jabbour EJ, Garcia-Manero G, Pemmaraju N, Pierce SA, Ghayas I, Short NJ, Montalban-Bravo G, Takahashi K, Assi R, Alotaibi AS, Ohanian M, Andreeff M, Cortes JE, Kantarjian HM, Ravandi F, Daver NG.
Yilmaz M, et al. Among authors: alfayez m.
J Hematol Oncol. 2020 Oct 8;13(1):132. doi: 10.1186/s13045-020-00964-5.
J Hematol Oncol. 2020.
PMID: 33032648
Free PMC article.